1. Home
  2. ZIMV vs DIAX Comparison

ZIMV vs DIAX Comparison

Compare ZIMV & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZIMV
  • DIAX
  • Stock Information
  • Founded
  • ZIMV 2021
  • DIAX 2005
  • Country
  • ZIMV United States
  • DIAX United States
  • Employees
  • ZIMV N/A
  • DIAX N/A
  • Industry
  • ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DIAX Finance Companies
  • Sector
  • ZIMV Health Care
  • DIAX Finance
  • Exchange
  • ZIMV Nasdaq
  • DIAX Nasdaq
  • Market Cap
  • ZIMV 532.4M
  • DIAX 521.1M
  • IPO Year
  • ZIMV N/A
  • DIAX N/A
  • Fundamental
  • Price
  • ZIMV $18.85
  • DIAX $14.72
  • Analyst Decision
  • ZIMV Hold
  • DIAX
  • Analyst Count
  • ZIMV 3
  • DIAX 0
  • Target Price
  • ZIMV $14.50
  • DIAX N/A
  • AVG Volume (30 Days)
  • ZIMV 651.9K
  • DIAX 96.6K
  • Earning Date
  • ZIMV 10-29-2025
  • DIAX 01-01-0001
  • Dividend Yield
  • ZIMV N/A
  • DIAX 7.93%
  • EPS Growth
  • ZIMV N/A
  • DIAX N/A
  • EPS
  • ZIMV N/A
  • DIAX N/A
  • Revenue
  • ZIMV $443,402,000.00
  • DIAX N/A
  • Revenue This Year
  • ZIMV $2.49
  • DIAX N/A
  • Revenue Next Year
  • ZIMV $1.26
  • DIAX N/A
  • P/E Ratio
  • ZIMV N/A
  • DIAX N/A
  • Revenue Growth
  • ZIMV N/A
  • DIAX N/A
  • 52 Week Low
  • ZIMV $8.15
  • DIAX $12.80
  • 52 Week High
  • ZIMV $19.01
  • DIAX $15.12
  • Technical
  • Relative Strength Index (RSI)
  • ZIMV 76.07
  • DIAX 64.07
  • Support Level
  • ZIMV $18.84
  • DIAX $14.60
  • Resistance Level
  • ZIMV $19.01
  • DIAX $14.80
  • Average True Range (ATR)
  • ZIMV 0.07
  • DIAX 0.11
  • MACD
  • ZIMV -0.27
  • DIAX 0.01
  • Stochastic Oscillator
  • ZIMV 5.88
  • DIAX 75.68

About ZIMV ZimVie Inc.

ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest

Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.

Share on Social Networks: